Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPulmonologyCarolina Diaphragm Pacing Policy Update | OpenPaye…
    Ask Trek AI about this page
    CurrentCarolina Behavioral Health AlliancePolicy CP.MP.203

    Diaphragmatic/Phrenic Nerve Stimulation

    Customize your policy alerts

    Sign up for carolinabehavioralhealth Policy CP.MP.203 alerts

    Get alerted when Policy CP.MP.203 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical necessity and coding for diaphragmatic/phrenic nerve stimulation systems used as an alternative to mechanical ventilation in individuals with severe, chronic respiratory failure. It applies to providers seeking coverage for Avery Mark IV or Spirit systems and the NeuRx RA/4 Diaphragm Pacing System.

    Policy Summary
    PayerCarolina Behavioral Health Alliance
    PolicyDiaphragmatic/Phrenic Nerve Stimulation
    Policy CodePolicy CP.MP.203
    Change TypeAdministrative and background update
    Effective DateN/A
    Next Review DateN/A
    Key ActionFor Medicare members and enrollees, review all applicable Medicare coverage guidance before applying this policy's criteria.
    SourceLink
    POLICY UPDATE CHANGES

    The 07/26 annual review updated background information, reviewed codes and descriptions, and updated references without changing the coverage criteria.

    2Device coverage pathways

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    4Avery Mark IV or Spirit criteria
    2NeuRx RA/4 indication groups
    4 hours/dayVentilator-free breathing requirement
    InsufficientEvidence for other conditions

    Medical Necessity and Covered Indications

    Avery Mark IV or Spirit system

    Covered as medically necessary when all criteria are met.

    • Qualifying underlying condition

      • Upper cervical spinal cord injury at or above the C3 vertebral level.At or above C3
      • Central alveolar hypoventilation disorder.
    • Required physiologic and functional criteria: All of the following are met: diaphragm movement with stimulation is visible under fluoroscopy; function of the phrenic nerve, lungs, and diaphragm is intact and sufficient; stimulation of the diaphragm, directly or through the phrenic nerve, results in sufficient muscle activity to accommodate independent breathing without ventilator support; and the individual has normal chest anatomy, a normal level of consciousness, and the ability to participate in and complete device training and rehabilitation.

    NeuRx RA/4 system

    Covered as medically necessary when provided in accordance with the NeuRx RA/4 Humanitarian Device Exemption specifications and all applicable criteria are met.

    NeuRx RA/4 Diaphragm Pacing System

    • Eligible NeuRx indication

      • Amyotrophic lateral sclerosis: The individual has amyotrophic lateral sclerosis (ALS); is age 21 years or older; is experiencing chronic hypoventilation but has not progressed to forced vital capacity (FVC) less than 45% predicted; diaphragm movement with stimulation is visible under fluoroscopy or by another radiographic technique such as ultrasound; and function of the phrenic nerve, lungs, and diaphragm is intact and sufficient.Age 21 years or older; FVC not less than 45% predicted
      • Upper cervical spinal cord injury: The individual has an upper cervical spinal cord injury at or above the C3 vertebral level; is age 18 years or older; diaphragm movement with stimulation is visible under fluoroscopy or by another radiographic technique such as ultrasound; stimulation of the diaphragm will allow the individual to breathe without mechanical ventilator assistance for at least four continuous hours per day; and function of the phrenic nerve, lungs, and diaphragm is intact and sufficient.

    Diaphragmatic/phrenic nerve stimulation is not covered or medically necessary for conditions other than the covered indications identified in this policy, including but not limited to central sleep apnea.

    The policy finds insufficient evidence to support the safety and efficacy of diaphragmatic/phrenic nerve stimulation for central sleep apnea and other conditions outside the listed covered indications. Although the Remedé System was FDA-approved for moderate to severe central sleep apnea in adults, its safety and effectiveness are not sufficiently established under this policy.

    Codes and Clinical Thresholds

    CPT CodesCPT
    64575Open implantation of neurostimulator electrode array; peripheral nerve (excludes sacral nerve).
    64580Open implantation of neurostimulator electrode array; neuromuscular.
    64590Insertion or replacement of peripheral, sacral, or gastric neurostimulator pulse generator or receiver, requiring pocket creation and connection between electrode array and pulse generator or receiver.
    64595Revision or removal of peripheral, sacral, or gastric neurostimulator pulse generator or receiver, with detachable connection to electrode array.
    HCPCS CodesHCPCS
    C1778Lead, neurostimulator (implantable).
    C1816Receiver and/or transmitter, neurostimulator (implantable).
    L8680Implantable neurostimulator electrode, each.
    L8681Patient programmer (external) for use with implantable programmable neurostimulator pulse generator, replacement only.
    L8682Implantable neurostimulator radiofrequency receiver.
    L8683Radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver.
    HCPCS CodesHCPCS
    L8685Implantable neurostimulator pulse generator, single array, rechargeable, includes extension.
    L8686Implantable neurostimulator pulse generator, single array, nonrechargeable, includes extension.
    L8687Implantable neurostimulator pulse generator, dual array, rechargeable, includes extension.
    L8688Implantable neurostimulator pulse generator, dual array, nonrechargeable, includes extension.
    L8689External recharging system for battery (internal) for use with implantable neurostimulator, replacement only.
    L8695External recharging system for battery (external) for use with implantable neurostimulator, replacement only.
    L8696Antenna (external) for use with implantable diaphragmatic/phrenic nerve stimulation device, replacement, each.
    Upper Cervical Spinal Cord Injury Level
    Qualifying levelAt or above the C3 vertebral level
    Underlying conditionUpper cervical spinal cord injury
    Clinical contextSevere, chronic respiratory failure requiring an alternative to mechanical ventilation
    ALS Forced Vital Capacity
    FVC thresholdNot less than 45% predicted
    Applicable conditionAmyotrophic lateral sclerosis (ALS) with chronic hypoventilation

    Documentation and Coverage Decision Risks

    Note

    Review Medicare Coverage Guidance

    For Medicare members/enrollees, review all applicable Medicare National Coverage Determinations, Local Coverage Determinations, and Medicare Coverage Articles before applying this policy’s criteria. Refer to the CMS website for current guidance.

    Documentation Required

    Document Qualifying Diagnosis and Respiratory Failure

    Document that stimulation is being used as an alternative to mechanical ventilation for severe, chronic respiratory failure caused by a qualifying condition. For the Mark IV Breathing Pacemaker System or Spirit Diaphragm Pacing Transmitter, the qualifying conditions are upper cervical spinal cord injury at or above C3 or central alveolar hypoventilation disorder.

    • Required: Severe, chronic respiratory failure.
    • Qualifying conditions: Upper cervical spinal cord injury at or above C3, or central alveolar hypoventilation disorder.

    Clinical Background

    Diaphragmatic/phrenic nerve stimulation, also called diaphragm pacing, uses electrical stimulation of the phrenic nerves or diaphragm to produce rhythmic diaphragm contractions and breathing. For selected ventilator-dependent individuals with chronic ventilatory insufficiency or failure, and with sufficient phrenic nerve, lung, and diaphragm function, this therapy may serve as an alternative to mechanical ventilation and may reduce or eliminate the need for ventilator support.

    Key Terms

    Diaphragmatic/Phrenic Nerve Stimulation
    DefinitionA treatment using electrical stimulation of the phrenic nerves to signal the diaphragm muscles to contract rhythmically and produce breathing
    Physiologic targetThe phrenic nerves and diaphragm muscles
    Clinical purposeTo help produce breathing in individuals with chronic ventilatory insufficiency or failure
    Diaphragm Pacing
    Synonymous termDiaphragm pacing is another term for diaphragmatic/phrenic nerve stimulation
    MechanismElectrical stimulation uses the phrenic nerves to signal rhythmic diaphragm muscle contractions
    Policy Summary
    PayerCarolina Behavioral Health Alliance
    PolicyDiaphragmatic/Phrenic Nerve Stimulation
    Policy CodePolicy CP.MP.203
    Change TypeAdministrative and background update
    Effective DateN/A
    Next Review DateN/A
    Key ActionFor Medicare members and enrollees, review all applicable Medicare coverage guidance before applying this policy's criteria.
    SourceLink
    On This Page
    Medical Necessity and Covered IndicationsCodes and Clinical ThresholdsDocumentation and Coverage Decision RisksClinical BackgroundKey Terms
    Age 18 years or older; injury at or above C3; at least 4 continuous ventilator-free hours per day
    Coverage boundary
    The individual must not have progressed to FVC less than 45% predicted
    NeuRx Spinal Cord Injury Ventilator-Free Breathing
    Minimum durationAt least four continuous hours per day
    Required abilityBreathing without the assistance of a mechanical ventilator
    Applicable pathwayNeuRx RA/4 system for stable, high spinal cord injury with a stimulatable diaphragm
    NeuRx ALS Minimum Age
    Minimum age21 years or older
    Applicable conditionAmyotrophic lateral sclerosis (ALS)
    Device pathwayNeuRx RA/4 Diaphragm Pacing System under the FDA humanitarian-use pathway
    NeuRx Spinal Cord Injury Minimum Age
    Minimum age18 years or older
    Applicable conditionStable, high spinal cord injury with a stimulatable diaphragm
    Required respiratory outcomeAbility to breathe without mechanical ventilator assistance for at least four continuous hours per day
    Documentation Required

    Document Radiographic Diaphragm Movement

    Provide diagnostic documentation showing that diaphragm movement with stimulation is visible under fluoroscopy for the Mark IV or Spirit system. For the NeuRx RA/4 system, fluoroscopy or another radiographic technique, such as ultrasound, may demonstrate the required movement.

    • Mark IV/Spirit: fluoroscopic evidence is required.
    • NeuRx RA/4: fluoroscopy or other radiographic evidence, such as ultrasound, is acceptable.
    Documentation Required

    Verify Phrenic Nerve, Lung, and Diaphragm Function

    Document intact and sufficient function of the phrenic nerve, lungs, and diaphragm, and show that direct or phrenic-nerve stimulation produces sufficient diaphragm muscle activity to support independent breathing without a ventilator.

    • Document intact and sufficient phrenic nerve, lung, and diaphragm function.
    • Document sufficient stimulated muscle activity for independent, ventilator-free breathing.
    Documentation Required

    Document Anatomy, Consciousness, and Rehabilitation Ability

    For the Mark IV or Spirit system, document normal chest anatomy, a normal level of consciousness, and the individual’s ability to participate in and complete the required device training and rehabilitation.

    • Normal chest anatomy.
    • Normal level of consciousness.
    • Ability to participate in and complete training and rehabilitation.
    Documentation Required

    Complete NeuRx Device-Specific Documentation

    For NeuRx RA/4, document compliance with the FDA Humanitarian Device Exemption specifications and the indication-specific requirements for ALS or upper cervical spinal cord injury.

    • ALS: Age 21 years or older; chronic hypoventilation; FVC not less than 45% predicted; radiographically visible diaphragm movement with stimulation; and intact, sufficient phrenic nerve, lung, and diaphragm function.
    • Upper cervical spinal cord injury at or above C3: Age 18 years or older; radiographically visible diaphragm movement with stimulation; ability to breathe without mechanical-ventilator assistance for at least four continuous hours daily; and intact, sufficient phrenic nerve, lung, and diaphragm function.
    Denial Risk

    Failure to Establish the Ventilator Alternative

    Coverage may be denied when diaphragmatic/phrenic nerve stimulation is not documented as an alternative to mechanical ventilation for severe, chronic respiratory failure.

    • Do not submit the system as a substitute for indications outside severe, chronic respiratory failure or as a stand-alone treatment without the required ventilator-alternative rationale.
    Denial Risk

    Insufficient Stimulation Response or Organ Function

    Coverage may be denied when stimulation does not produce visible diaphragm movement or when the individual lacks intact and sufficient phrenic nerve, lung, or diaphragm function. For the Mark IV or Spirit system, insufficient stimulated muscle activity to support independent breathing is also a denial risk.

    • No visible diaphragm movement on the required imaging.
    • Insufficient phrenic nerve, lung, or diaphragm function.
    • Insufficient stimulated muscle activity for independent breathing.
    Denial Risk

    Unlisted Conditions and Central Sleep Apnea

    The policy states that evidence is insufficient to support the safety and efficacy of diaphragmatic/phrenic nerve stimulation for conditions other than the listed indications, including central sleep apnea.

    • Unlisted conditions are not supported by this policy.
    • Central sleep apnea is specifically identified as an example of a condition with insufficient evidence.
    Denial Risk

    NeuRx Indication Requirements Not Met

    NeuRx coverage may be denied when any indication-specific requirement is absent, including the applicable minimum age, ALS chronic hypoventilation without FVC below 45% predicted, radiographic diaphragm movement, or the required ventilator-free breathing capability for spinal cord injury.

    • ALS: age must be 21 years or older and FVC must not have progressed to less than 45% predicted.
    • Upper cervical spinal cord injury: age must be 18 years or older.
    • For upper cervical spinal cord injury, documentation must show breathing without mechanical-ventilator assistance for at least four continuous hours per day.
    Intended benefit
    To eliminate or reduce the need for mechanical ventilator support
    Humanitarian Device Exemption (HDE)
    MeaningAn FDA humanitarian-use pathway for the NeuRx RA/4 Diaphragm Pacing System
    ALS requirementsFor specified ALS patients with a stimulatable diaphragm, chronic hypoventilation, and FVC not less than 45% predicted; use is limited to patients 21 years of age or older
    Spinal cord injury requirementsFor specified patients with stable, high spinal cord injuries and stimulatable diaphragms who lack diaphragm control; use is limited to patients 18 years of age or older
    Respiratory outcomeThe system is indicated to allow qualifying spinal cord injury patients to breathe without mechanical ventilator assistance for at least four continuous hours per day